Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio - Business Wire
businesswire.comSubmitted by businesswire3560 in business
Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (NASDAQ: RYZB) today announced a definitive merger agreement under which Bristol Myers Squibb will